Page last updated: 2024-11-05

trifluoperazine and Graves Ophthalmopathy

trifluoperazine has been researched along with Graves Ophthalmopathy in 1 studies

Graves Ophthalmopathy: An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, L1
Ji, QH1
Ruge, F1
Lane, C1
Morris, D1
Tee, AR1
Dayan, CM1
Ludgate, M1

Other Studies

1 other study available for trifluoperazine and Graves Ophthalmopathy

ArticleYear
Reversal of Pathological Features of Graves' Orbitopathy by Activation of Forkhead Transcription Factors, FOXOs.
    The Journal of clinical endocrinology and metabolism, 2016, Volume: 101, Issue:1

    Topics: Adipogenesis; Adult; Female; Forkhead Transcription Factors; Glucuronosyltransferase; Graves Ophthal

2016